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Abstract We have used the yeast two-hybrid system to search
for cytoplasmic proteins that might assist in the intracellular
trafficking of the soluble L-galactoside-binding protein, galectin-
3. We utilised as bait murine full-length galectin-3 to screen a
murine 3T3 cDNA library. Several interacting clones were found
to encode a partial open reading frame and a full-length clone
was obtained by rapid amplification of cDNA ends methodology.
In various assays in vitro the novel protein was shown to bind
galectin-3 in a carbohydrate-independent manner. The novel
protein contains an unusually high content of cysteine and
histidine residues and shows significant sequence homologies with
several metal ion-binding motifs present in known proteins.
Confocal immunofluorescence microscopy of permeabilised 3T3
cells shows a prominent perinuclear, as well as cytoplasmic,
localisation of the novel protein.
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1. Introduction
Galectins are intracellular, carbohydrate-binding proteins
that are present in many organisms and are believed to have
a variety of functions intra- and extracellularly [1^3]. Galec-
tin-3, although lacking any conventional signal sequence, can
be secreted by novel, as yet incompletely understood, path-
ways circumventing the endoplasmic reticulum^Golgi complex
involved in classical secretory pathways [4^7]. Galectin-3 has
also been found within the cell nucleus [8,9]. In murine 3T3
¢broblasts, the lectin appears to re-locate from the cytoplasm
predominantly to the nucleoplasm in proliferating cells [10^
13]. The pathway(s) by which galectin-3 enters the nucleus are
unknown. The galectin-3 sequence contains no reasonable
classical nuclear localisation signal [14].
By analogy to the case of L-catenin, that shows a similar
shuttling from the cytoplasm either to plasma membrane do-
mains or into the nucleus [15] regulated by complex formation
with the LEF-1 transcription factor [16] and other factors [17],
we considered the possibility that intracellularly galectin-3
may combine with cytoplasmic proteins that function to
direct the lectin into the nucleus or into secretory pathways.
Therefore, we have undertaken a yeast two-hybrid screening
in an attempt to identify cytoplasmic binding partners of
galectin-3.
2. Materials and methods
2.1. Yeast two-hybrid screening
Bait plasmid was generated by inserting the complete open reading
frame (ORF) of mouse galectin-3 [18], kindly provided by J.L. Wang,
University of Michigan, East Lancing, MI, USA, into the yeast vector
pGBD-C3 [19], using EcoRI^BglII sites, to produce in-frame fusions
with the GAL4 DNA-binding domain. Plasmids were transformed
into Saccharomyces cerevisiae strain CG1945 (Clontech) and selec-
tants were checked for expression of fusion proteins by immunoblot-
ting yeast lysates with anti-galectin-3 [20] or with anti-GAL4 DNA-
binding domain antibodies (Clontech). A cDNA library of mouse
embryonic NIH/3T3 ¢broblasts cloned in the pACTII vector carrying
a haemagglutinin (HA) tag (Clontech) was transformed into S. cere-
visiae strain Y187 and the yeast transformants carrying the bait were
used to screen this library using an improved mating strategy [21].
Approximately 107 clones were screened and the His clones were
further tested for LacZ expression by L-galactosidase assay using
5-bromo-4-chloro-3-indolyl-L-D-galactoside as a substrate. Interacting
cDNA clones were retrieved by transformation of competent Esche-
richia coli DH5K cells with DNA extracted from yeast clones and
identi¢ed by sequencing with GAL4 activation domain primers. Pos-
itive clones were checked for interaction by reintroduction into strain
Y187 and mating with yeast cells containing the bait. The speci¢city
of interaction was checked by mating library clones with CG1945
containing the empty pGBD-C3 vector as well as various combina-
tions of constructs in pGBD-C3, such as that encoding the mouse
desmocollin-1a cytoplasmic domain.
2.2. 5P-Rapid ampli¢cation of cDNA ends (RACE)
The 5P-RACE System Version 2 (Life Technologies) was used to
carry out 5P-RACE. 1 Wg of mouse kidney mRNA (Clontech) was
converted to ¢rst strand cDNA using gene-speci¢c reverse primer 5P-
TGATCATATAGTTGTGTGAAGCTGCTGCCA-3P corresponding
to 67 bp downstream of the putative stop codon in the two-hybrid
positive clones, and poly(A)-tailed using recombinant terminal deoxy-
nucleotidyl transferase. 5 Wl of the tailed cDNA was ampli¢ed using a
second gene-speci¢c primer 5P-GGACAGCACTACCGGACTG-
CAGCC-3P located 28 bp downstream of the putative stop codon,
and the abridged anchor primer 5P-GGCCACGCGTCGACTAG-
TACTTTTTTTTTTTTTTTTTTTTTTTT-3P. PCR was carried out
using AmpliTaq Gold polymerase (Perkin-Elmer). 5 Wl of a 1^100
dilution of the PCR products was re-ampli¢ed using gene-speci¢c
primer 5P-GATATCGATTTACTTCTGTATCTGGAACAG-3P and
anchor primer 5P-GGCCACGCGTCGACTAGTAC-3P. PCR prod-
ucts were gel-puri¢ed and digested with SalI and ClaI restriction
enzymes and cloned into pBluescript II SK+ vector (Stratagene). Sin-
gle clones were grown overnight and plasmid DNA was prepared
using a Hybaid kit.
2.3. DNA sequencing and analysis
DNA sequencing was performed using the ABI Prism Big Dye
Terminator Cycle Sequencing kit (Perkin-Elmer Applied Biosystems),
and the reactions were analysed using an ABI Prism DNA Sequencer
(Perkin-Elmer). Sequence analysis of two-hybrid-positive clones was
performed using an on-line BLAST search and the Laser Gene Soft-
ware for Macintosh (DNASTAR, Madison, WI, USA). The EMBL/
GenBank accession number for the full-length cDNA is AJ251516.
2.4. Production of antibodies
An EcoRI^XhoI digest of the positive clone 4.4 was ligated to
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pGEX-6P-2 (Pharmacia) to make an in-frame fusion with glutathione-
S-transferase (GST). After bacterial expression, the GST fusion pro-
tein was puri¢ed on a glutathione-Sepharose column (Pharmacia) and
used to raise polyclonal antibodies in rabbits. Absorption of the anti-
serum was carried out using GST protein coated onto glutathione-
Sepharose beads.
2.5. Immunoprecipitation
Yeast cells carrying the bait and the positive clones were grown in
LWH medium (2 ml). Cells were pelleted and lysed in ice cold lysis
bu¡er (50 mM Tris, 150 mM NaCl, 0.5% NP-40, pH 7.4) containing
protease inhibitors (Boehringer). The lysate was cleared of cell debris
by centrifugation and immunoprecipitated with anti-galectin-3 poly-
clonal antibody raised [20] in rabbits. Immune complexes were col-
lected onto protein A-Sepharose at 4‡C overnight and separated by
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE). After transfer to nitrocellulose, the blot was probed with
anti-HA mouse monoclonal antibody 12CA5 (Babco, Richmond,
CA, USA). The ¢lters were then stripped and reprobed with the
Mac-2 rat monoclonal antibody (Boehringer Mannheim) to reveal
the presence of galectin-3.
3T3 cells were grown to con£uency in F 15 medium (Gibco) con-
taining 10% FCS and the cells were washed once with phosphate-
bu¡ered saline (PBS) and lysed in RIPA bu¡er (50 mM Tris^HCl
pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% sodium deoxycholate,
1.0% NP-40, 0.1% SDS). Lysates were cleared of cell debris and im-
munoprecipitated with anti-galectin-3 or anti-GST fusion protein anti-
bodies. Cell lysates were pre-cleared with anti-GST antibodies (Phar-
macia) prior to immunoprecipitation with anti-GST fusion protein
antibodies. Immune complexes were separated by SDS^PAGE and
blotted with Mac-2 antibody.
2.6. In vitro transcription/translation
PCR was carried out on pBluescript SK+ vector carrying the clone
obtained by 5P-RACE using primers: 5P-ATAGAATTCATGGTTTC-
CAAACCCAGGACT-3P and 5P-AGAGGATCCTTACTTCTG-
TATCTGGAACAGG-3P. The ampli¢ed ORF was cloned into expres-
sion vector pSG5 [22] using EcoRI and BamHI restriction sites.
Proteins were synthesised in medium containing [35S]methionine
(Amersham-Pharmacia Biotech) using the above plasmid DNA carry-
ing the ampli¢ed ORF, or pSG5 carrying a full-length mouse galectin-
3 insert, with the Promega TNT Quick Coupled Transcription/Trans-
lation System. Empty pSG5 vector was used as a control. Translated
proteins were either analysed directly or the reaction mixtures were
diluted with lysis bu¡er, mixed 1:1 by volume and incubated at 4‡C
on a rocking platform for 1 h. After addition of Mac-2 antibody,
immune complexes bound to protein A-Sepharose were subjected to
SDS^PAGE and autoradiography.
2.7. Bead binding assay
E. coli BL 21DE3 cells were transformed with pGEX-6P-1 vector
carrying in-frame fusions of the full-length ORF of the interacting
protein and cells were induced for 4 h with 0.1 mM isopropyl-1-
thio-L-D-galactopyranoside. The cells were washed with PBS, solubi-
lised in lysis bu¡er and lysates were incubated with glutathione-
Sepharose beads for 2 h followed by extensive washing with lysis
bu¡er. 100 Wl of beads was incubated for 2 h with 100 Wl (40 Wg) of
recombinant full-length hamster galectin-3 or a C-terminal galectin-3
carbohydrate recognition domain (CRD) fragment lacking the ¢rst
94 residues [20]. As a control, beads were incubated with GST-trans-
formed BL 21DE3 lysates. The beads were washed with lysis bu¡er
and subjected to SDS^PAGE and Western blotting with antibodies
recognising the galectin-3 CRD [20].
2.8. Northern analysis
1 Wg of mRNA prepared from 3T3 ¢broblasts was electrophoresed
through 1.1% agarose/6.6% formaldehyde gels, transferred to Hybond
N membranes (Amersham) and hybridised at 68‡C with a 1065 bp
EcoRI^XhoI fragment from clone 4.4 that was 32P-labelled using
Ready-To-Go DNA labelling beads (Pharmacia). The RNA hybrid-
isation bu¡er contained 6USSC, 2UDenhardt’s reagent, 0.1% SDS
and 20 Wg sonicated salmon sperm DNA. The blots were hybridised
overnight and washed once with 1USSC, 0.1% SDS for 20 min at
room temperature and three times with 0.2USSC, 0.1% SDS for
20 min each at 68‡C, followed by autoradiography. Tissue-speci¢c
expression of the newly identi¢ed gene was tested by probing mouse
multiple tissue Northern blots (Clontech) with a PCR-derived frag-
ment from the full-length clone encoding a 453 bp region showing
homology to a human brain mRNA, according to the manufacturer’s
instructions.
2.9. Immuno£uorescence microscopy
Sub-con£uent 3T3 cells grown on glass coverslips were ¢xed in 3%
paraformaldehyde in PBS for 30 min at room temperature, permea-
bilised with 0.1% NP-40 in PBS for 5 min and non-speci¢c binding
sites were blocked with 2% BSA in PBS for 15 min. For double
staining, the cells were ¢rst incubated with rat monoclonal Mac-2
antibody, washed and incubated with goat anti-rat Ig-FITC. After
washing with PBS, the cells were incubated with rabbit polyclonal
antibodies against the GST^clone 4.4 fusion protein, washed and in-
cubated with goat anti-rabbit Ig-Texas red. As controls, cells were
stained only with second antibodies or with goat anti-GST antibody
(Pharmacia) followed by sheep anti-goat Ig-FITC.
3. Results and discussion
By screening a mouse 3T3 embryonic ¢broblast library,
using the yeast two-hybrid system, we identi¢ed 34 out of
51 positive clones encoding fragments apparently belonging
to a single class of cDNA. One clone, 4.4, had an interacting
ORF consisting of 209 amino acids and a putative 3P-untrans-
lated region of 415 bp, containing a potential polyadenylation
site ahead of the poly(A) tail. To identify the 5P-sequence of
the interacting clone, a 5P-RACE strategy was performed that
yielded a further 544 bp at the 5P-end with a putative start
codon in a Kozak consensus sequence [23] and an in-frame
stop codon upstream of the start codon. The predicted amino
acid sequence of this cDNA (Fig. 1) indicated an exception-
ally high content of cysteine (17 residues) and histidine (11
residues) in a total of 311 residues. 14 cysteine and seven
histidine residues reside within an N-terminal domain (resi-
dues 30^140) of the protein. Hence this protein is referred
to provisionally as cysteine/histidine-rich protein (Chrp).
Northern blotting of mRNA derived from 3T3 cells re-
vealed two transcripts of approximately 4.3 kb and 1.7 kb
(Fig. 2A). cDNA library screening indicated that the smaller
transcript is derived by alternative polyadenylation (results
not shown). Northern blotting of mouse tissues (Fig. 2A)
revealed variable expression of Chrp mRNA with highest ex-
pression in liver, heart and kidney. Interestingly, although
Chrp (Fig. 2A) and galectin-3 (Fig. 2B) mRNAs are co-ex-
pressed at similar levels in liver and kidney, they show diver-
gent expression in other tissues.
The speci¢city of Chrp^galectin-3 interactions was demon-
strated by co-precipitation of these proteins from lysates of
yeast cells (Fig. 3a) as well as from 3T3 cells (Fig. 3b) express-
ing both proteins. Since, in the former case, the cells carry the
partial clone 4.4 encoding only a small part of the cysteine/
histidine-rich region, it appears likely that this region is not
involved in interactions with galectin-3. However, more work
is required to map more exactly the galectin-3 interacting site
Fig. 1. Deduced amino acid sequence of Chrp. The cysteine/histi-
dine-rich region is underlined.
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in the C-terminal domains of Chrp. Further evidence for the
interaction between Chrp and galectin-3 was obtained from in
vitro transcription/translation experiments using rabbit retic-
ulocyte lysates. Galectin-3 and Chrp were independently
translated and the synthesised proteins were mixed and im-
munoprecipitated with lectin-speci¢c antibodies. The immune
complexes contained two proteins having molecular weights
expected of galectin-3 (approximately 32 kDa) and Chrp (ap-
proximately 38 kDa), respectively (Fig. 3c). Finally, recombi-
nant galectin-3 was found to bind to bacterially expressed
Chrp (Fig. 3d), as did a galectin-3 CRD fragment lacking
the N-terminal domains of the native protein (Fig. 3d).
Thus, although interactions between Chrp and galectin-3 are
clearly carbohydrate-independent, they do involve the carbo-
hydrate-binding domain of the lectin.
Using confocal immuno£uorescence microscopy, double la-
belling of 3T3 cells showed a distinct di¡erence in the local-
isation of Chrp and galectin-3. Although both proteins clearly
resided at least in part in the cytoplasm, Chrp was strikingly
concentrated at the nuclear envelope in a concentric ring (Fig.
4b): this appearance was found in optical cross sections taken
at 1 W intervals throughout the thickness of the cells. Chrp
appeared to be excluded from the nucleus (Fig. 4b). By con-
trast, galectin-3 was found (Fig. 4a) within the nucleus, except
for the nucleoli, in agreement with previous ¢ndings in 3T3
cells [9].
An initial BLAST search, using the nucleotide sequence of
the partial clone 4.4, showed some homology to a human
chromosome 1-speci¢c mRNA transcript (GenBank accession
no. KIAA0496) [24]. When the full-length Chrp sequence was
compared, a region of 453 bp showed almost complete ho-
mology at the nucleotide level to a region in the 6151 bp
human mRNA. This encodes 151 amino acids, starting with
the 31QCTNGHL in the cysteine/histidine-rich N-terminal do-
main (Fig. 1). A BLAST search using the complete Chrp se-
quence revealed further homology in this region with cysteine/
histidine-rich zinc ¢nger motifs [25] from a variety of proteins.
Some representative examples are shown in Fig. 5. Thus, res-
idues 115^140 of the Chrp sequence show (Fig. 5) conserva-
Fig. 2. Northern blot analysis. 1 Wg of poly(A) RNA obtained
from 3T3 cells was hybridised with clone 4.4 insert. 2 Wg of poly-
(A) RNA from each indicated mouse tissue was probed with a
453 bp Chrp cDNA fragment (upper panel). This blot was stripped
and reprobed with galectin-3 cDNA (lower panel). A parallel blot
was hybridised with a L-actin probe to ensure normalisation of the
amount of RNA loaded in each lane (data not shown). The sizes of
RNA standards are indicated.
Fig. 3. Interactions of Chrp with galectin-3. a: Yeast cells co-ex-
pressing the bait fusion protein galectin-3/GAL4 DNA-binding do-
main and the HA-tagged clone 4.4 protein were lysed and immuno-
precipitated with polyclonal antibody against galectin-3. Immune
complexes collected on protein A-Sepharose were subjected to SDS^
PAGE and blotted with anti-HA monoclonal antibody. After strip-
ping, the same ¢lter was then blotted with anti-galectin-3 Mac-2
monoclonal antibody. The migrations of HA-tagged Chrp (44 kDa,
open arrow head) and the galectin-3 fusion protein (60 kDa, closed
arrow head) are indicated. b: 3T3 cells were immunoprecipitated
with polyclonal antibodies raised against Chrp or galectin-3 as indi-
cated. A control pre-immune serum was also used. Immune com-
plexes were blotted after SDS^PAGE with monoclonal antibody di-
rected against galectin-3. The migration of galectin-3 (approximately
32 kDa, arrow head) is indicated. c: In vitro transcription/transla-
tion was carried out with control pSG5 vector, vector carrying in-
serts of either mouse galectin-3 or Chrp. Samples of the
[35S]methionine-labelled products were subjected to SDS^PAGE fol-
lowed by autoradiography. Samples of the in vitro produced galec-
tin-3 and Chrp were also mixed, incubated at 4‡C for 1 h and im-
munoprecipitated with polyclonal anti-galectin-3 antibody. Immune
complexes were run on SDS^PAGE followed by autoradiography.
Note the co-precipitation of a 32 kDa galectin-3 band and a 38
kDa Chrp band. d: Recombinant hamster galectin-3 or a CRD
fragment lacking N-terminal residues 1^94 were incubated with
GST^Chrp fusion protein adsorbed onto glutathione-Sepharose
beads. Beads were washed and bound proteins were subjected to
SDS^PAGE followed by Western blotting with anti-galectin-3 CRD
antibodies.
FEBS 23450 23-3-00 Cyaan Magenta Geel Zwart
R.P. Menon et al./FEBS Letters 470 (2000) 227^231 229
tion of all cysteine and histidine residues present in a zinc
¢nger in the Drosophila TNF receptor-associated factor 1
[26] and homologous sequences occurring in the Drosophila
RING ¢nger gene sina and its murine and human siah homo-
logues [27]. These proteins appear to participate in signal
transduction involving tyrosine kinases. Several studies have
shown that single zinc ¢nger peptides can fold in the presence
of metal ions such as Zn2 or Co2 [28,29]. Therefore, it is an
intriguing possibility that the cysteine/histidine-rich region in
Chrp may function like the metal-binding domains in other
proteins, for example in DNA and RNA-binding [25], in en-
zyme catalysis [30] as well as in protein^protein interactions
and signal transduction [28].
At present, the functional signi¢cance of speci¢c interac-
tions between galectin-3 and Chrp are unknown. We have
recently shown that N-terminal residues of galectin-3 are es-
sential for secretion [6,7]. Thus, the observation that Chrp can
bind to a galectin-3 CRD fragment lacking these residues
suggests that Chrp is not involved in galectin-3 secretion. By
contrast, recent studies indicate that the galectin-3 CRD is
su⁄cient for nuclear expression (J.-C. Gaudin and R.C.
Hughes, unpublished results). Galectin-3 binds to ssDNA
and RNAs [13,31] and has been implicated in pre-mRNA
splicing [32]. Therefore, it is interesting to ask if interactions
between Chrp and galectin-3 are involved in any of these
events. However, we have not been able to detect the presence
of Chrp inside the nucleus, which perhaps argues against any
putative role of Chrp/galectin-3 interactions in nuclear import
or function. Interestingly, several mammalian inhibitors of
apoptosis proteins (IAPs) [33] are known to possess cys-
teine/histidine-rich motifs termed BIRs [34] and RING-zinc
¢ngers [35^37]. IAPs lacking C-terminal RING ¢ngers and
possessing one or more BIRs have been reported [38,39].
Even though the cysteine/histidine-rich motif in Chrp is not
in agreement with the consensus BIR- or RING-zinc ¢nger
motif found in IAPs, given the proposed role of galectin-3 as
an inhibitor of apoptosis [40,41], it is possible that Chrp too is
involved in apoptosis regulation, particularly since its cellular
localisation is somewhat similar to bcl-2 [42]. However, there
is no sequence similarity between Chrp and bcl-2.
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